Coronary artery disease in heart transplantation: new concepts for an old disease

M Langstraat, KJS Musters, O Manintveld… - Transplant …, 2018 - Wiley Online Library
Cardiac allograft vasculopathy (CAV) remains one of the main long‐term complications after
heart transplantation. We performed a systematic review focused on articles published in the …

Changes in outcomes of cardiac allograft vasculopathy over 30 years following heart transplantation

M Tremblay-Gravel, N Racine, S de Denus… - JACC: Heart Failure, 2017 - jacc.org
Objectives: This study investigated temporal changes in the demographics and the
prognosis of cardiac allograft vasculopathy (CAV) over 30 years following heart …

The association between cytomegalovirus infection and cardiac allograft vasculopathy in the era of antiviral valganciclovir prophylaxis

D Klimczak-Tomaniak, S Roest, JJ Brugts… - …, 2020 - journals.lww.com
Background. Previous studies on the association between cytomegalovirus (CMV) infection
and cardiac allograft vasculopathy (CAV) were conducted on patients transplanted in the …

Combined heart and kidney transplantation—Is there a protective effect against cardiac allograft vasculopathy using intravascular ultrasound?

T Sato, R Cheng, B Azarbal, M Kittleson, J Patel… - The Journal of Heart and …, 2019 - Elsevier
BACKGROUND Because cardiac and renal disease are physiologically related and often
coexist, the prevalence of combined heart and kidney transplantation (HKTx) has …

Immunosuppression in Cardiac Transplantation

Y Xie, KW Lor, JA Kobashigawa - Cardiac Surgery: A Complete Guide, 2020 - Springer
Immunosuppression has revolutionized transplantation and improved outcomes. The
immunosuppression goal is to balance rejection prevention with side effects, toxicities, and …